个性化文献订阅>期刊> Journal of Biological Chemistry
 

Isolation of a TRAIL Antagonist from the Serum of HIV-infected Patients

  作者 Schnepple, DJ; Shepard, B; Bren, GD; Cummins, NW; Natesampillai, S; Trushin, S; Algeciras-Schimnich, A; Meng, XW; Sainski, AM; Rizza, SA; Kaufmann, SH; Badley, AD  
  选自 期刊  Journal of Biological Chemistry;  卷期  2011年286-41;  页码  35742-35754  
  关联知识点  
 

[摘要]Virus-host interactions are characterized by the selection of adaptive mechanisms by which to evade pathogenic and defense mechanisms, respectively. In primary T cells infected with HIV, HIV infection up-regulates TNF-related apoptosis inducing ligand (TRAIL) and death-inducing TRAIL receptors, but blockade of TRAIL: TRAIL receptor interaction does not alter HIV-induced cell death. Instead, HIV infection results in a novel splice variant that we call TRAIL-short (TRAIL-s), which antagonizes TRAIL-R2. In HIV patients, plasma TRAIL-s concentration increases with increasing viral load and renders cells resistant to TRAIL-induced death. Knockdown of TRAIL-s abrogates this resistance. We propose that TRAIL-s is a novel adaptive mechanism of apoptosis resistance acquired by HIV-infected cells to avoid their elimination by TRAIL-dependent effector mechanism.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内